Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1916 (LINC01916) is a human gene that encodes a long non-coding RNA classified as a long intergenic non-protein coding RNA (lincRNA)[1]. LincRNAs are defined as autonomously transcribed non-coding RNA molecules longer than 200 nucleotides that do not overlap annotated protein-coding genes[3][7]. While the broader class of lincRNAs participates in diverse gene regulation processes—including chromatin remodeling, transcription regulation, and RNA stabilization—there are currently no published studies detailing the specific biological function, interacting molecules, disease relevance, or clinical applications of LINC01916[1][3]. As such, LINC01916 is not currently considered a therapeutic target, receptor, or clinically actionable biomarker, and therapeutic interventions or safety concerns specific to it have not been reported[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1916 (LINC01916).